Where We’re Going
Toragen is preparing to initiate a Phase I clinical trial with its lead compound in HPV-associated malignancies and is seeking investor funding for research and development.
Toragen is preparing to initiate a Phase I clinical trial with its lead compound in HPV-associated malignancies and is seeking investor funding for research and development.
Toragen, Inc. 